Definitive Contract 75D30119C06635
- Not listed
- The federal contract award, ID 75D30123C16926, was granted to Emory University by the Centers for Disease Control and Prevention (CDC) for a Broad Agency Announcement (BAA) topic 33.1. The $1,807,738.00 Firm Fixed Price contract has a completion date of September 10, 2026. Emory University, a private research university in Atlanta, Georgia, will provide products and services under this contract through its Office of Sponsored Programs Division. The contract is not set aside for any specific...
- Emory University Office of Sponsored Programs Division was awarded a $96,146 firm fixed price contract by the Centers for Disease Control and Prevention for support of the SARS COV-2 Broad Agency Announcement. No set-aside designation was applied. Work will be performed in Atlanta, Georgia through March 2022. This contract is likely associated with Emory University's previously awarded multiple award indefinite delivery contract from the CDC worth up to $86 million to provide clinical...
- This is a $367,096 firm fixed-price purchase order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Emory University, a private research university, for IT software. The contract has a completion date of February 16, 2023 and was awarded on February 13, 2020. Emory University is a non-profit organization that has an extensive track record of performing federally funded research and providing services to the government through contracts...
- Emory University has been awarded a firm fixed price definitive contract valued at approximately $1.78 million by the Centers for Disease Control and Prevention (CDC) to support Topic 7.1 of the agency's Fiscal Year 2021 Broad Agency Announcement (BAA). As the prime contractor, Emory University will perform the work at its location in Chamblee, Georgia. The period of performance is August 1, 2021 through July 31, 2023. While details of the work requirements are not provided in the award...
- This $571,955.88 firm fixed-price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) to Emory University, a private research university in Atlanta, Georgia. The contract is for serological testing services and does not have a set-aside designation. Emory University has an extensive track record of performing federally funded research and providing services to government agencies through contracts and grants, including in areas such as infectious disease...
- This is a delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Emory University, a private research university in Atlanta, Georgia. The contract is for $125,123.27 in firm fixed-price laboratory analysis services. It has a completion date of September 15, 2023. Emory University is the prime contractor on this contract, which is not set aside for any specific socioeconomic category. Emory is a major recipient of federal research contracts and grants,...
- This is a sole-source, firm-fixed-price contract awarded by the Centers for Disease Control and Prevention (CDC) to Emory University, a private research university, for the provision of clinical care and medical emergency treatment services. The contract has a ceiling value of $8,050,959.09 and a period of performance through February 28, 2026. The contract is not set aside for any socioeconomic category. Emory University is a major recipient of federal funding, with expertise in biomedical...
- This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Emory University, a private research institution in Atlanta, Georgia. The contract is for $149,824.00 and is for LAB TESTING services. It has an ultimate completion date of April 30, 2017. Emory University is the prime contractor, and there is no set-aside designation for this award. As a leading academic and research center, Emory University has an extensive track record of...
- This contract, awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Emory University, is for "BLOOD DRAW #2 COVID 19" services. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed price of $144,665.85. The period of performance ends on September 30, 2020. Emory University, a private research university located in Atlanta, Georgia, has an extensive track record of performing federally funded research and...
- This is a $248,999.00 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Emory University for a study of biological specimens from persons receiving daily oral doxycycline. The contract has an ultimate completion date of August 31, 2025. Emory University is a private research university located in Atlanta, Georgia, known for its expertise in biomedical research, public health, and healthcare innovation. The contract is not set aside for...
This is a definitive, firm-fixed price contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Emory University. The contract, valued at $630,506.00, is for services performed under the 2019 Broad Agency Announcement (BAA) and has a completion date of May 15, 2022. Emory University is a private research university that has an extensive track record of performing federally funded research and providing services to the government through contracts and grants. This contract is likely related to Emory's work supporting the CDC's Clinical Immunization Safety Assessment (CISA) program, as Emory holds a multiple award indefinite delivery contract with the CDC for these services. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Other Administrative Action | ($6k) | 5/25/24 | |
| P00002 | Other Administrative Action | $0 | 8/12/21 | |
| P00001 | Other Administrative Action | $0 | 3/24/20 | |
| Not listed | Not listed | $630.5k | 9/6/19 |